Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

Creative Commons License

Kalyoncu U., Ogdie A., Campbell W., Bingham C. O., de Wit M., Gladman D. D., ...More

RMD OPEN, vol.2, no.1, 2016 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 2 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.1136/rmdopen-2015-000217
  • Journal Name: RMD OPEN
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Hacettepe University Affiliated: Yes


The objectives of this systematic literature review (SLR) were to identify domains and outcome measures used in psoriatic arthritis (PsA) studies in the past 5 years, and to compare the measurement of the Outcome Measures in Rheumatology (OMERACT) 2006 PsA Core Domain Set in studies published in 2010-2015 vs those published in 2006-2010. We performed a systematic literature search in two databases, PubMed and Embase, to identify randomised controlled trials (RCTs) in PsA. We also identified PsA longitudinal observational studies (LOS). Three patient research partners provided input into study conception, and data collection and interpretation. We identified 41 studies representing 22 unique RCTs, 27 LOS and 12 registries. Across all studies, we identified 24 domains and 169 outcome measures. In addition to the PsA Core Domain Set (6 domains), the following domains were also assessed in more than 30% of RCTs: acute phase reactants, dactylitis, enthesitis, fatigue and work productivity. We identified a range of 1-15 outcome measures per domain with a mean (SD) of 7 (4.7) per domain. The complete PsA Core Domain Set was assessed in 59% of RCTs in 2010-2015 compared to 23.5% RCTs in 2006-2010. There has been increased measurement of the PsA Core Domain Set in RCTs and LOS in the past 5 years. Numerous additional outcomes were also measured. The PsA Core Domain Set needs an update to standardise PsA outcome assessments. This SLR will inform the development of an updated PsA Core Domain Set with patient research partner input.